DCM
CELG

Diag Capital Management’s Celgene Corp CELG Stock Holding History

Diag Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		$4.05M Buy
+63,159
New +$4.66M 4.63% 7

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Diag Capital Management's CELG Position: Q4 2018 in Review

Diag Capital Management opened a new position in Celgene Corp (CELG) in Q4 2018: 63,159 shares worth $4.05M. The stake represents 4.63% of the portfolio and ranks #7 among its holdings.

1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Diag Capital Management held 63,159 shares of Celgene Corp worth $4.05M as of Q4 2018.
  • Celgene Corp was a new Diag Capital Management position in Q4 2018.
  • Celgene Corp made up 4.63% of Diag Capital Management's portfolio in Q4 2018, its #7 holding.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Diag Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.